We are live on
!
Find out more
RA
Royce & Associates Portfolio holdings
AUM
$10.1B
1-Year Est. Return
42.88%
This Fund
S&P 500
This Quarter
Est. Return
-27.19%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$7.34B
AUM Growth
-$3.86B
(-34%)
Cap. Flow
-$375M
Cap. Flow
% of AUM
-5.12%
Top 10 Holdings %
Top 10 Hldgs %
9.89%
Holding
1,223
New
86
Increased
388
Reduced
436
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESCO Technologies
ESE
|
+$40.8M |
| 2 |
Haemonetics
HAE
|
+$37.6M |
| 3 |
Rogers Corp
ROG
|
+$26.2M |
| 4 |
Evercore
EVR
|
+$25.5M |
| 5 |
FARO
Faro Technologies
FARO
|
+$22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVX
AVX Corporation
AVX
|
+$71.1M |
| 2 |
Virtu Financial
VIRT
|
+$51M |
| 3 |
Allegiant Air
ALGT
|
+$26.6M |
| 4 |
Kirby Corp
KEX
|
+$26.3M |
| 5 |
Franklin Electric
FELE
|
+$26.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 25.72% |
| 2 | Technology | 19.64% |
| 3 | Financials | 14.17% |
| 4 | Consumer Discretionary | 10.37% |
| 5 | Healthcare | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
NACCO Industries
NC
$357M
| $27K | ﹤0.01% |
966
+143
| +17% | +$5.89K |
|
1077
Arq
ARQ
$84.6M
| $27K | ﹤0.01% |
+4,170
| New | +$40.5K |
|
1078
Smart Sand
SND
$185M
| $25K | ﹤0.01% |
24,406
+12,001
| +97% | +$20.3K |
|
|
NEX
1079
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $25K | ﹤0.01% |
+21,211
| New | +$93.1K |
|
1080
Old Second Bancorp
OSBC
$1.29B
| $24K | ﹤0.01% |
3,463
+545
| +19% | +$6K |
|
1081
PCB Bancorp
PCB
$392M
| $24K | ﹤0.01% |
2,453
+413
| +20% | +$5.7K |
|
1082
Parke Bancorp
PKBK
$401M
| $24K | ﹤0.01% |
+1,748
| New | +$33.1K |
|
1083
INNOVATE Corp
VATE
$111M
| $24K | ﹤0.01% |
1,560
-732
| -32% | -$21.1K |
|
1084
Atlanticus Holdings
ATLC
$1.59B
| $22K | ﹤0.01% |
+2,194
| New | +$25.7K |
|
1085
First Internet Bancorp
INBK
$257M
| $22K | ﹤0.01% |
1,332
-59
| -4% | -$1.36K |
|
|
FONR
1086
DELISTED
Fonar
FONR
| $21K | ﹤0.01% |
1,404
-16
| -1% | -$296 |
|
|
BCIC
1087
BCP Investment Corp
BCIC
$89.1M
| $21K | ﹤0.01% |
2,204
| – | – |
|
1088
Lexicon Pharmaceuticals
LXRX
$1.03B
| $20K | ﹤0.01% |
10,189
+4,769
| +88% | +$14.2K |
|
1089
MVB Financial
MVBF
$397M
| $20K | ﹤0.01% |
+1,606
| New | +$29.7K |
|
1090
Revolve Group
RVLV
$1.8B
| $20K | ﹤0.01% |
2,336
+469
| +25% | +$7.44K |
|
|
RVLP
1091
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $20K | ﹤0.01% |
+6,184
| New | +$32.9K |
|
1092
Ironwood Pharmaceuticals
IRWD
$696M
| $19K | ﹤0.01% |
+1,865
| New | +$21.9K |
|
1093
LifeVantage
LFVN
$81.1M
| $19K | ﹤0.01% |
1,832
+199
| +12% | +$2.73K |
|
1094
Tactile Systems Technology
TCMD
$635M
| $19K | ﹤0.01% |
480
+70
| +17% | +$3.75K |
|
1095
Willis Lease Finance
WLFC
$1.7B
| $19K | ﹤0.01% |
2,148
+432
| +25% | +$7.15K |
|
|
SFE
1096
DELISTED
Safeguard Scientifics, Inc.
SFE
| $19K | ﹤0.01% |
3,402
+1,442
| +74% | +$12.9K |
|
1097
Destination XL Group
DXLG
$31.2M
| $18K | ﹤0.01% |
50,000
| – | – |
|
|
ELVT
1098
DELISTED
Elevate Credit, Inc.
ELVT
| $18K | ﹤0.01% |
17,627
+4,227
| +32% | +$15.2K |
|
|
HMHC
1099
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $18K | ﹤0.01% |
9,743
+616
| +7% | +$3.13K |
|
|
TNAV
1100
DELISTED
Telenav Inc.
TNAV
| $18K | ﹤0.01% |
4,092
-1,098
| -21% | -$5.66K |
|
Similar funds
GI
IIM
ACA
VPIM
RI
OIA
HRCM
FPAS
Royce & Associates's Q1 2020 Portfolio in Review
As of Q1 2020, Royce & Associates held 1,223 positions worth $7.34B, down 34% from $11.2B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
Royce & Associates withdrew a net $375M in Q1 2020, closing 75 positions and reducing 436 holdings. Its most notable exit was AVX Corporation, an estimated $71.1M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
Against the trend, Royce & Associates opened a new position in ESCO Technologies worth $33.9M.
- Royce & Associates's largest Q1 2020 buy was ESCO Technologies: 447,118 shares worth $33.9M.
- Royce & Associates added most to Haemonetics in Q1 2020, an estimated $37.6M increase.
- Royce & Associates's biggest Q1 2020 reduction was Virtu Financial, cutting an estimated $51M.
- Royce & Associates fully exited AVX Corporation in Q1 2020, selling an estimated $71.1M.
- Royce & Associates's ten largest holdings make up 9.9% of its $7.34B portfolio in Q1 2020.
- Royce & Associates opened 86 new positions and closed 75 in Q1 2020.
- Royce & Associates's portfolio value fell 34% quarter-over-quarter to $7.34B.
Based on Royce & Associates's 13F filing for Q1 2020, filed 12 May 2020.